- Regulating the price of patented drugs. Buske, Lynda // CMAJ: Canadian Medical Association Journal;05/15/97, Vol. 156 Issue 10, p1512
Focuses on drug prices in Canada from the 1988 to the 1990s. Drop in drug expenditures increases between 1987 and 1994; Price increases for patented and nonpatented drugs.
- Coalition seeks access to drug discounts. // AHA News;1/27/97, Vol. 33 Issue 3, p3
Reports that cooperative purchasing of drugs does not increase overall prices according to a study made by Public Hospital Pharmacy Coalition.
- International page. // DCI;Apr94, Vol. 154 Issue 4, p9
Reports on the setback of Europe's move to phase out price controls on pharmaceuticals when the European Union's Executive Commission rejected the notion.
- The art (and science) of pricing prescriptions. // Drug Store News;2/12/96, Vol. 18 Issue 3, p25
Focuses on the pricing of prescription drugs in the United States, based on statistical data provided by ProfitLink McKesson Corp. Variation of prescription drug pricing from region to region; Pricing of the top 15 drugs in the midwestern and southern states; Division between the top 200 drugs...
- Studies renew price-curb talk. Weissenstein, Eric // Modern Healthcare;2/7/94, Vol. 24 Issue 6, p17
Reports on two Congressional studies on the pharmaceutical industry's pricing policies. Calls for regulation by lawmakers; Rise in drug prices in 1993; Comparison with retail inflation rate; Cost differences between the United States and Great Britain.
- HCFA taking hard look at drug costs. // Drug Topics;11/7/94, Vol. 138 Issue 21, p8
Reports that the Health Care Financing Administration is trying to develop an estimate of the difference between the actual acquisition cost of prescriptions and the AWP.
- Rx price rise. // Drug Topics;1/23/95, Vol. 139 Issue 2, p52
Reports on the increase of prices pharmaceuticals in the United States in 1994.
- The French way of controlling drug costs. Watson, Rory // BMJ: British Medical Journal (International Edition);4/22/95, Vol. 310 Issue 6986, p1028
Describes an experiment introduced in France in 1994 to reduce the annual rise in public expenditure on drugs without affecting health care. Strategies used to persuade doctors to prescribe economically; Authorities' agreements with pharmaceutical companies involving them in the shared aim of...
- Prescription drug prices rise slightly. // H&HN: Hospitals & Health Networks;3/20/94, Vol. 68 Issue 6, p30
Reports on First DataBank's findings on the average price increase for all prescription drug products. Top 25 pharmaceutical companies with lower average increases; Higher rate of increase for generic products.
- Extreme answers to prescription drug costs. Colhoun, Alexander // Christian Science Monitor;4/18/2000, Vol. 92 Issue 102, p3
Reports that elderly citizens of the United States that live near the border with Canada often travel there to purchase pharmaceuticals at a much lower cost than that for which they available in the US, and discusses government concern over this fact.